Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.
The Europe viscosupplementation market has been estimated to be valued at US$ 192.0 Mn in 2015 and is expected to expand at a CAGR of 5.1% over the forecast period (2016–2026).
The Europe viscosupplementation market is segmented on the basis of product and end user.
Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. Single injection viscosupplementation product type segment is expected to exhibit the highest growth over the forecast period.
Based on end users, the market has been segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals segment currently accounts for the highest revenue share in the Europe viscosupplementation market. Orthopaedic clinics segment is also gaining prominence in Europe due to upcoming attractive reimbursement options and patient preference for single injection cycle over multiple injection cycle treatment.
Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-eu-1383
Summary of Table of Content:
1. Research Methodology
2. Assumptions and Acronyms Used
3. Executive Summary
4. Viscosupplementation Market Overview
5. Europe Viscosupplementation Market Forecast, By Product Type
6. Europe Viscosupplementation Market Forecast, By End Use
7. Europe Viscosupplementation Market Forecast, By Region
8. Western Europe Viscosupplementation Market Analysis
9. Eastern Europe Viscosupplementation Market Analysis
10. Competition Landscape
Request to BrowseTable of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/europe-viscosupplementation-market/toc
The Europe viscosupplementation market has been estimated to be valued at US$ 192.0 Mn in 2015 and is expected to expand at a CAGR of 5.1% over the forecast period (2016–2026).
The Europe viscosupplementation market is segmented on the basis of product and end user.
Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. Single injection viscosupplementation product type segment is expected to exhibit the highest growth over the forecast period.
Based on end users, the market has been segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals segment currently accounts for the highest revenue share in the Europe viscosupplementation market. Orthopaedic clinics segment is also gaining prominence in Europe due to upcoming attractive reimbursement options and patient preference for single injection cycle over multiple injection cycle treatment.
Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-eu-1383
Summary of Table of Content:
1. Research Methodology
2. Assumptions and Acronyms Used
3. Executive Summary
4. Viscosupplementation Market Overview
5. Europe Viscosupplementation Market Forecast, By Product Type
6. Europe Viscosupplementation Market Forecast, By End Use
7. Europe Viscosupplementation Market Forecast, By Region
8. Western Europe Viscosupplementation Market Analysis
9. Eastern Europe Viscosupplementation Market Analysis
10. Competition Landscape
Request to BrowseTable of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/europe-viscosupplementation-market/toc
No comments:
Post a Comment